<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AiM</journal-id><journal-title-group><journal-title>Advances in Microbiology</journal-title></journal-title-group><issn pub-type="epub">2165-3402</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aim.2016.614099</article-id><article-id pub-id-type="publisher-id">AiM-73013</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Enantioselective Conversion of Racemic Felodipine to S(-)-Felodipine by &lt;i&gt;Aspergillus niger&lt;/i&gt; and Lipase AP6 Enzyme
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chandupatla</surname><given-names>Vijitha</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ettireddy</surname><given-names>Swetha</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ciddi</surname><given-names>Veeresham</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>University College of Pharmaceutical Sciences, Kakatiya University, Warangal, India</addr-line></aff><pub-date pub-type="epub"><day>07</day><month>12</month><year>2016</year></pub-date><volume>06</volume><issue>14</issue><fpage>1062</fpage><lpage>1074</lpage><history><date date-type="received"><day>November</day>	<month>22,</month>	<year>2016</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>December</month>	<year>24,</year>	</date><date date-type="accepted"><day>December</day>	<month>27,</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   The present study involves the enantioselective resolution of racemic Felodipine by using free and immobilized forms of microbial cultures as well as an enzyme (Lipase AP6). Among the microbial cultures employed in the present study, 
   Aspergillus niger
   , 
   Sphingomonas paucimobilis, Cunninghamella elegans, Escherichia coli, Pseudomonas putida
    and 
   Cunninghamella blakesleeana
    were found to possess capability of enantioselective resolution of racemic Felodipine. The enantiomeric excess (ee%) of Felodipine after reaction catalyzed by whole-cell 
   A. niger
    and 
   S. paucimobilis
    was found as 81.59 and 71.67%, respectively. Immobilization enhanced the enantioselectivity (enantiomeric ratio (E)) of the biocatalysts and hence this led to enhanced enantiomeric purity of the drug. The ee% values were found to be enhanced in reactions catalyzed by 
   A. niger
    and 
   S. paucimobilis
    cultures after immobilization as 98.27 and 93.56%, respectively. Enantiomeric ratio (E) of the reactions catalyzed by all the biocatalysts has been improved after immobilization. E value of the reaction catalyzed by immobilized A. niger was found to be excellent (E &gt; 100) and hence the drug showed high enantiomeric purity. In lipase AP6 catalyzed study, the enantioselectivity was enhanced after immobilization with excellent E value, which led to enhanced enantiomeric purity of the drug (99.21% ee%). 
  
 
</p></abstract><kwd-group><kwd>Racemic Felodipine</kwd><kwd> Enantioselective Conversion</kwd><kwd> Biocatalysts</kwd><kwd> Immobilization</kwd><kwd>  Lipase AP6</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Chirality is a fundamental property of biological systems and drug efficacy [<xref ref-type="bibr" rid="scirp.73013-ref1">1</xref>] . Interactions of drugs with receptors, enzymes or binding sites have long been known to be stereoselective. The two enantiomers of drugs often act differently with each other in bioenvironment and the enantiomers can exhibit different pharmacokinetic and pharmacodynamic properties [<xref ref-type="bibr" rid="scirp.73013-ref2">2</xref>] . The differences in pharmacodynamic and pharmacokinetic properties of enantiomer are related to the differences in affinity or intrinsic activity at receptor sites. The pharmacological activity may reside only in one enantiomer, while the other may be inactive or have desirable or undesirable activity [<xref ref-type="bibr" rid="scirp.73013-ref3">3</xref>] .</p><p>Production of the chiral molecule is one of the rapidly progressing fields of modern science. Importance of this field is growing continuously due to various therapeutic benefits of single enantiomer over racemate [<xref ref-type="bibr" rid="scirp.73013-ref4">4</xref>] . Besides the chemical methods, biocatalytic methods were also proved to be effective towards the generation of single active enantiomer from its racemate and the use of biocatalysts had been growing rapidly for the past few years [<xref ref-type="bibr" rid="scirp.73013-ref2">2</xref>] . Microorganisms have been shown the capacity for performing a wide range of metabolic biotransformations such as enantiomeric inversion and biocatalytic deracemization processes leading to enantiomerically pure compounds [<xref ref-type="bibr" rid="scirp.73013-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.73013-ref6">6</xref>] .</p><p>Felodipine belongs to the dihydropyridine class of calcium channel blocker indicated for the treatment of hypertension and stable angina pectoris. It possesses a chiral centre at the 4<sup>th</sup> position in the 1,4-dihydropyridine nucleus and exists as two enantiomeric forms [<xref ref-type="bibr" rid="scirp.73013-ref7">7</xref>] . It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, Felodipine prevents calcium-dependent mycolyte contraction and vasoconstriction. S(−)-Felodipine was proved to be 3 times more potent than R(+)-Felodipine in an in vitro assay for coronary vasoconstriction. An in vivo study with spontaneously hypertensive rats showed that S(−)-Felodipine was 3 times more potent in lowering blood pressure [<xref ref-type="bibr" rid="scirp.73013-ref8">8</xref>] .</p><p>In view of this, it is important to use single active enantiomer rather than a racemate and hence in the present work the enantioselective conversion of racemic Felodipine to its active enantiomer by using the microbial cultures and enzyme was studied. To date, there are no reports available for biocatalytic transformation of Felodipine into its active S(−)-Felodipine. The microorganisms selected for the biotransformation study include Bacillus subtilis [<xref ref-type="bibr" rid="scirp.73013-ref9">9</xref>] , Escherichia coli [<xref ref-type="bibr" rid="scirp.73013-ref10">10</xref>] , Pseudomonas putida [<xref ref-type="bibr" rid="scirp.73013-ref11">11</xref>] , Sphingomonas paucimobilis [<xref ref-type="bibr" rid="scirp.73013-ref12">12</xref>] , Rhodococcus erythropolis [<xref ref-type="bibr" rid="scirp.73013-ref13">13</xref>] , Streptomyces halstedii [<xref ref-type="bibr" rid="scirp.73013-ref14">14</xref>] , Aspergillus niger [<xref ref-type="bibr" rid="scirp.73013-ref15">15</xref>] , Geotricum candidum [<xref ref-type="bibr" rid="scirp.73013-ref16">16</xref>] , Rhizopus oryzae [<xref ref-type="bibr" rid="scirp.73013-ref17">17</xref>] , Candida parapsilosis [<xref ref-type="bibr" rid="scirp.73013-ref18">18</xref>] , Cunninghamella elegans [<xref ref-type="bibr" rid="scirp.73013-ref19">19</xref>] , Cunninghamella blakesleeana [<xref ref-type="bibr" rid="scirp.73013-ref20">20</xref>] and enzyme triacylglycerol lipase from Aspergillus niger (Lipase AP6) [<xref ref-type="bibr" rid="scirp.73013-ref21">21</xref>] .</p></sec><sec id="s2"><title>2. Materials</title><sec id="s2_1"><title>2.1. Chemicals</title><p>Racemic Felodipine was a gift sample from Aurobindo Pharmaceuticals Pvt. Ltd., Hyderabad (India). The enantiomers R(+)-Felodipine and S(−)-Felodipine were separated by Diacel Chiral Technologies (India) Pvt. Ltd., Hyderabad (India). Suitable growth media, triacylglycerol lipase from A. niger and all other chemicals were purchased from Hi-Media Laboratories Pvt. Ltd., Mumbai, India. The HPLC grade solvents were purchased from Sigma Aldrich Chemicals Pvt. Ltd., Mumbai (India). Analytical grade solvents purchased from Finar limited, Gujarat, India.</p></sec><sec id="s2_2"><title>2.2. Microorganisms</title><p>The selected microbial cultures were purchased from Microbial Type Culture Collection and Gene Bank (MTCC), Chandigarh or National Collection of Industrial Microorganisms (NCIM), Pune, India. The cultures were revived, subcultured and stored in refrigerator at 4˚C. The bacterial and fungal cultures were maintained on suitable growth media.</p></sec><sec id="s2_3"><title>2.3. Instrumentation</title><p>Incubation was done in refrigerated shaker incubator of model Innova 4230, New Brunswick Scientific Co., Inc. (NJ, USA). Sample analysis was done by using a chiral column (Lux Cellulose-4; 250 &#215; 4.6 mm; 5 &#181; particle size) purchased from Phenomenex (USA) and an Ultra Fast Liquid Chromatograph of Shimadzu (Kyoto, Japan) equipped with binary pump (LC 20AD), UV/Visible detector (LC 20A) and Rheodyne injector port. Lab solutions software was used for the HPLC analysis.</p></sec></sec><sec id="s3"><title>3. Experimental Methods</title><sec id="s3_1"><title>3.1. Culture Procedure</title><p>In regular biotransformation experiments, a two stage fermentation protocol was followed. A loopful of culture from freshly grown agar slant was inoculated into 25 mL of sterile liquid growth medium and the flask was incubated at specific growth conditions (<xref ref-type="table" rid="table1">Table 1</xref>), at 120 rpm. After incubation this culture was considered as first stage culture and 500 &#181;l of this culture inoculum was added to freshly prepared sterile liquid growth medium (25 mL) and was incubated at specific growth conditions at 120 rpm. After incubation, these second stage cultures were employed for the biotransformation studies. Fungal cultures were supplemented with 0.02% triton &#215; 100 in order to get good dispersion of fungi in the media [<xref ref-type="bibr" rid="scirp.73013-ref22">22</xref>] .</p></sec><sec id="s3_2"><title>3.2. Enantioselective Resolution of Felodipine Using Whole-Cell Microorganisms</title><p>The racemic Felodipine (2.5 mg/mL in methanol) was added to the second stage suspension cultures of all experimental organisms (25 mL culture in 100 mL capacity conical flask). Prior to addition, the drug solution was filter sterilized using sterile syringe driven PVDF hydrophilic membrane filters (pore size―0.22 &#181;m). The flasks were gently shaken immediately after the addition of drug for its even distribution. Each culture was studied in triplicate (n = 3) while running suitable controls. Culture controls consisted of culture blanks in which the organisms were grown under identical conditions and instead of substrate these were added with 100 &#181;L of methanol. Drug</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Growth conditions for selected microbial cultures</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Name of the Microorganism MTCC/NCIM Accession no. (Equivalent strain no.)</th><th align="center" valign="middle" >Growth Media</th><th align="center" valign="middle" >Temperature (&#176;C)</th><th align="center" valign="middle" >Incubation period (d)</th><th align="center" valign="middle" >Growth Condition</th></tr></thead><tr><td align="center" valign="middle" >Escherichia coli MTCC 448 (ATCC9637)</td><td align="center" valign="middle" >Nutrient agar medium</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Bacillus subtilis MTCC 1305</td><td align="center" valign="middle" >Nutrient agar medium</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Pseudomonas putida MTCC 102 (NCIB9494)</td><td align="center" valign="middle" >Nutrient agar medium</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Sphingomonas paucimobilis MTCC 1919 (NCTC11030)</td><td align="center" valign="middle" >Nutrient agar medium</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Candida parapsilosis MTCC 998 (13)</td><td align="center" valign="middle" >Malt yeast agar medium</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Geotrichum candidum MTCC 3993 (HA780)</td><td align="center" valign="middle" >Malt yeast agar medium</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Rhodococcus erythropolis MTCC 1548 (DSM43188)</td><td align="center" valign="middle" >Streptomyces medium</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Streptomyces halstedii MTCC 6817 (CKM-2)</td><td align="center" valign="middle" >Streptomyces medium</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >2 - 3</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Aspergillus niger MTCC 9687 (GUFCC5443)</td><td align="center" valign="middle" >Malt extract agar medium</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Rhizopus oryzae MTCC 262 (NCIM1009)</td><td align="center" valign="middle" >Potato dextrose agar medium</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Cunninghamella elegans NCIM 689</td><td align="center" valign="middle" >Potato dextrose agar medium</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >Aerobic</td></tr><tr><td align="center" valign="middle" >Cunninghamella blakesleeana MTCC 3729 (CBS133.27)</td><td align="center" valign="middle" >Potato dextrose agar medium</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >Aerobic</td></tr></tbody></table></table-wrap><p>controls were composed of sterile medium to which same amount of drug was added and incubated without microorganisms. The incubation was continued under similar conditions for 20 days and the samples were collected at the time intervals of 3<sup>rd</sup>, 5<sup>th</sup>, 10<sup>th</sup>, 15<sup>th</sup>, 20<sup>th</sup> day, extracted and analyzed by chiral HPLC [<xref ref-type="bibr" rid="scirp.73013-ref23">23</xref>] .</p></sec><sec id="s3_3"><title>3.3. Enantioselective Resolution of Felodipine Using Immobilized Microorganisms</title><p>The entrapment method was adopted for immobilization of whole-cell microorganism of Pawar et al. (2012) [<xref ref-type="bibr" rid="scirp.73013-ref24">24</xref>] . The cells, which were previously washed with dipotassium hydrogen phosphate saline solution, were mixed with 3% sodium alginate solution with continuous stirring. The resulting suspension was added to an aqueous solution of calcium chloride (50 mM) in a drop wise manner. Calcium alginate beads were allowed to stand for 1h for hardening. The hardened beads were washed with distilled water and used for the biotransformation.</p><p>The organisms which were responded to whole-cell biotransformation were selected for immobilization method. Maximum enantioselective conversion of Felodipine was found in 10<sup>th</sup> day samples and hence in the immobilization study incubation was carried up to 10 days. The study was carried with suitable controls. Immobilized cells without drug substrate were considered as culture controls and drug in buffer solution without immobilized cells was considered as drug control. Both of these were maintained in phosphate buffer solution (0.5% K<sub>2</sub>HPO<sub>4</sub> and 0.5% NaCl). All the culture flasks, except culture controls, were added with 2.5 mg/mL of the drug in methanol and were incubated in refrigerator incubator at 120 rpm for 10 days. Triplicate (n = 3) of the study was adopted.</p></sec><sec id="s3_4"><title>3.4. Extraction and Sample Preparation of Felodipine</title><p>The samples from the culture flasks were collected at specified time intervals, and three volumes of ethyl acetate was added and vortexed for 1 min [<xref ref-type="bibr" rid="scirp.73013-ref25">25</xref>] . All the organic layers of ethyl acetate were combined and evaporated under vacuum and dried. The dried extracts were reconstituted with 1 ml of HPLC methanol and filtered with sterile syringe filter, and used for further analysis.</p></sec><sec id="s3_5"><title>3.5. Enantioselective Resolution of Felodipine Using Free Enzyme</title><p>The reaction mixture was composed of n-hexane and isopropanol (6:4) along with racemic Felodipine (2.5 mg/mL) in methanol. The reaction was started by adding lipase (10 mg/mL) to the reaction mixture [<xref ref-type="bibr" rid="scirp.73013-ref26">26</xref>] and was incubated at 120 rpm, at 25˚C for 36 h. Samples were collected at intervals of 4<sup>th</sup>, 8<sup>th</sup>, 12<sup>th</sup>, 16<sup>th</sup>, 20<sup>th</sup>, 24<sup>th</sup>, 28<sup>th</sup>, 32<sup>nd</sup>, 36<sup>th</sup> h and evaporated at room temperature. The residues were dissolved in methanol (HPLC grade), filtered through membrane filter (pore size―0.22 &#181;m) and analyzed by chiral HPLC.</p></sec><sec id="s3_6"><title>3.6. Enantioselective Resolution of Felodipine Using Immobilized Enzyme</title><p>Enzyme immobilization was done by reported method [<xref ref-type="bibr" rid="scirp.73013-ref24">24</xref>] with few modifications. Briefly, enzyme (10 g/L) was suspended in sterile phosphate buffer (pH 6.8) and was mixed with equal volume of sodium alginate solution (3% w/v). Using a syringe, this suspension was extruded into calcium chloride solution (0.2 M) from a height of 15 cm to yield calcium alginate beads (2 mm) and kept aside (1 h) for hardening. Then they were washed thrice with distilled water and employed for the study by adding them into reaction mixture along with racemic Felodipine (2.5 mg/mL methanol). Reaction mixture with enzyme-alginate beads and without drug was considered as blank, while the drug control consisted of reaction mixture with the drug and without beads. All the test and controls were incubated at 25˚C at 120 rpm for 36 h, samples were collected (4<sup>th</sup>, 8<sup>th</sup>, 12<sup>th</sup>, 16<sup>th</sup>, 20<sup>th</sup>, 24<sup>th</sup>, 28<sup>th</sup>, 32<sup>nd</sup>, 36<sup>th</sup> h) and evaporated at room temperature. The residues were dissolved in methanol (HPLC grade), filtered through membrane filter (pore size―0.22 &#181;m) and analyzed by chiral HPLC.</p></sec><sec id="s3_7"><title>3.7. Chromatographic Analysis</title><p>The samples collected were analyzed by previously reported chiral HPLC method of Xu et al. [<xref ref-type="bibr" rid="scirp.73013-ref27">27</xref>] . The chromatographic conditions were shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>Enantiomeric ratio (E) is the parameter characteristic of the enantioselectivity of a particular biocatalyst and is independent of substrate concentration. It can be calculated by the formula [<xref ref-type="bibr" rid="scirp.73013-ref28">28</xref>] ;</p><disp-formula id="scirp.73013-formula158"><graphic  xlink:href="http://html.scirp.org/file/8-2270870x2.png"  xlink:type="simple"/></disp-formula><p>where ‘eep’ is the enantiomeric excess of the product.</p><p>Enantiomeric excess (ee %) and extent of conversion (C %) were calculated by using the following formulae [<xref ref-type="bibr" rid="scirp.73013-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.73013-ref30">30</xref>] .</p><disp-formula id="scirp.73013-formula159"><graphic  xlink:href="http://html.scirp.org/file/8-2270870x3.png"  xlink:type="simple"/></disp-formula><p>where R, S are the peak areas of the individual enantiomers and R<sub>0</sub>, S<sub>0</sub> are the values of initial peak areas of the enantiomers.</p></sec></sec><sec id="s4"><title>4. Results and Discussion</title><p>Racemic Felodipine was analysed by the reported chiral HPLC method and the chromatogram was shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Retention time of S(−)- and R(+)-Felodipine were found to be 14.16 and 20.22 min, respectively. Among the microbial cultures employed in the whole-cell catalyzed bioconversion study, six microbial cultures A. niger, S. paucimobilis, C. elegans, E. coli, P. putida and C. blakesleeana were able to catalyze the re-</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Chromatographic conditions</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Stationary phase (Type of column)</th><th align="center" valign="middle" >Lux Cellulose-4; 250 &#215; 4.6 mm; 5 &#181; particle size (cellulose-tris(4-chloro-3-methyl phenyl carbamate)</th></tr></thead><tr><td align="center" valign="middle" >Mobile phase</td><td align="center" valign="middle" >n-Hexane:Isopropanol (90:10)</td></tr><tr><td align="center" valign="middle" >Flow rate</td><td align="center" valign="middle" >1 mL/min</td></tr><tr><td align="center" valign="middle" >Injection volume</td><td align="center" valign="middle" >20 &#181;L</td></tr><tr><td align="center" valign="middle" >Detection wavelength</td><td align="center" valign="middle" >254 nm</td></tr></tbody></table></table-wrap><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Chromatogram of racemic Felodipine (1 &#181;g/mL)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/8-2270870x4.png"/></fig><p>action with excess of the S(−)-Felodipine with the conversion rate ranges in between 25 to 55%. The enantiomeric purity of the drug was assessed by calculating the enantiomeric excess (ee%), conversion yield (C%) and enantiomeric ratio (E) and were shown in <xref ref-type="table" rid="table3">Table 3</xref>. The enantioselective conversion with the whole-cell cultures gradually increased upto 10<sup>th</sup> day of incubation and the maximum enantiomeric excess was obtained with 10<sup>th</sup> day samples. Among the whole-cell cultures catalysed studies, A. niger has given good enantiomeric excess while the remaining cultures yielded moderate enantiomeric excesses. Though all these cultures responded for the moderate to good enantioselective conversion, their enantioselectivity (enantiomeric ratio E) was found to be worst to poor.</p><p>The biocatalyst enantioselectivity can be improved by immobilization [<xref ref-type="bibr" rid="scirp.73013-ref32">32</xref>] . Hence all these cultures were immobilized. The reactions catalysed by immobilized cultures have yielded good enantiomeric purity of the drug. This may be due to immobilization which improved the enantioselectivity of the microbial cultures. E value of the reaction catalysed by A.niger was improved from poor to excellent after immobilization. Hence, the enantiomeric purity of the reaction was very good with ee% of 98.27% while the E value of the reaction catalysed by S. paucimobilis was improved from poor to good and hence yielded good enantiomeric purity after immobilization. The E values of reactions catalysed by C. elegans, E. coli and P. putida were improved from worst to moderate and hence resulted in enhanced enantiomeric excess after immobilization. E value of the reaction catalysed by C. blaksleana was improved from worst to poor and the enantiomeric excess was also enhanced after immobilization. Overall, immobilization of microbial cultures has leads to enhanced enantioselectivity of these cultures which resulted in improved enantiomeric purity of the drug when compared to the reaction catalysed by whole-cell cultures. The C% also enhanced after immobilization. The present results are in accordance with that of Ribeiro et al. (2014) where he has reported that the immobilized cells of Kluyveromyces marxianus resulted in enantioselective</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Enantiomeric purity of Felodipine after incubation with the whole-cell as well as immobilized-cell cultures for 10 days</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >S. No</th><th align="center" valign="middle"  rowspan="2"  >Microorganism</th><th align="center" valign="middle"  colspan="3"  >Whole-cell incubation</th><th align="center" valign="middle"  colspan="3"  >Immobilized-cell incubation</th></tr></thead><tr><td align="center" valign="middle" >ee (%)</td><td align="center" valign="middle" >E*</td><td align="center" valign="middle" >C (%)</td><td align="center" valign="middle" >ee (%)</td><td align="center" valign="middle" >E*</td><td align="center" valign="middle" >C (%)</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Aspergillus niger</td><td align="center" valign="middle" >81.59</td><td align="center" valign="middle" >9.87</td><td align="center" valign="middle" >54.82</td><td align="center" valign="middle" >98.27</td><td align="center" valign="middle" >114.56</td><td align="center" valign="middle" >60.11</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Sphingomonas paucimobilis</td><td align="center" valign="middle" >71.67</td><td align="center" valign="middle" >6.06</td><td align="center" valign="middle" >47.44</td><td align="center" valign="middle" >93.56</td><td align="center" valign="middle" >30.06</td><td align="center" valign="middle" >54.21</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Cunninghamella elegans</td><td align="center" valign="middle" >64.88</td><td align="center" valign="middle" >4.69</td><td align="center" valign="middle" >47.03</td><td align="center" valign="middle" >87.38</td><td align="center" valign="middle" >14.84</td><td align="center" valign="middle" >36.26</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >60.75</td><td align="center" valign="middle" >4.09</td><td align="center" valign="middle" >42.28</td><td align="center" valign="middle" >83.18</td><td align="center" valign="middle" >10.22</td><td align="center" valign="middle" >53.23</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >Pseudomonas putida</td><td align="center" valign="middle" >60.81</td><td align="center" valign="middle" >4.10</td><td align="center" valign="middle" >31.95</td><td align="center" valign="middle" >83.48</td><td align="center" valign="middle" >11.10</td><td align="center" valign="middle" >42.23</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >Cunninghamella blakesleeana</td><td align="center" valign="middle" >56.79</td><td align="center" valign="middle" >3.62</td><td align="center" valign="middle" >27.40</td><td align="center" valign="middle" >81.37</td><td align="center" valign="middle" >9.73</td><td align="center" valign="middle" >28.90</td></tr></tbody></table></table-wrap><p>ee (%)―Enantiomeric excess, (C%)―Conversion yield, E―Enantiomeric ratio; *E value is considered as worst (1 - 5), poor (5 - 10), moderate (10 - 20), good (20 - 100) and excellent (&gt;100) [<xref ref-type="bibr" rid="scirp.73013-ref31">31</xref>] .</p><p>reduction of benzyl acetoacetate to benzyl (S)-3-hydroxybutanoate with high enantiomeric excess (76%) and conversion rate (99%) than the free cells which resulted in low enantiomeric excess and conversion values (68% and 80% respectively) [<xref ref-type="bibr" rid="scirp.73013-ref33">33</xref>] . The results were also in line with Tamalampudi et al. (2007) and according to them (RS)-1- phenylethanol was enantioselectively transesterified to (R)-1-phenylethyl acetate by using immobilized recombinant Aspergillus oryzae expressing lipase-encoding gene from Candida antarctica, which resulted with an enantiomeric excess (ee) of &gt;99%. The enantiomeric purity of (R)-1-phenylethyl acetate was found to be high when compared to that of the reaction catalyzed by whole-cell cultures [<xref ref-type="bibr" rid="scirp.73013-ref34">34</xref>] . The chromatograms of Felodipine after incubating with whole-cell and immobilized A. niger and S. paucimobilis cultures were shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>(a) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(b) and <xref ref-type="fig" rid="fig3">Figure 3</xref>(a) and <xref ref-type="fig" rid="fig3">Figure 3</xref>(b), respectively.</p><p>Among all reactions catalysed by immobilized cultures highest enantiomeric excess was resulted by immobilized A. niger and S. paucimobilis. This may be due to the presence of lipase enzyme is reported to be present in A. niger [<xref ref-type="bibr" rid="scirp.73013-ref35">35</xref>] . Lipase AP6 (Triacylglycerol lipase from A. niger) has employed as biocatalyst for the enantioselective conversion of racemic Felodipine. Enantiomeric purity of the drug after incubation with free and immobilized enzyme was shown in <xref ref-type="table" rid="table4">Table 4</xref>. The enantioselectivity of the</p><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Chromatogram of Felodipine after incubation with (a) Whole-cell A. niger culture; (b) Immobilized A. niger culture</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/8-2270870x5.png"/></fig><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Chromatogram of Felodipine after incubation with (a) Whole-cell S. paucimobilis culture; (b) Immobilized S. paucimobilis culture</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/8-2270870x6.png"/></fig><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Enantiomeric purity of Felodipine after incubation with free- and immobilized enzyme for 24 h</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >State of Biocatalyst</th><th align="center" valign="middle" >Enantiomeric excess (ee%)</th><th align="center" valign="middle" >Enantiomeric ratio (E)*</th><th align="center" valign="middle" >Conversion yield (C%)</th></tr></thead><tr><td align="center" valign="middle" >Free-enzyme</td><td align="center" valign="middle" >87.15</td><td align="center" valign="middle" >14.56</td><td align="center" valign="middle" >46.29</td></tr><tr><td align="center" valign="middle" >Immobilized-enzyme</td><td align="center" valign="middle" >99.21</td><td align="center" valign="middle" >252.58</td><td align="center" valign="middle" >71.12</td></tr></tbody></table></table-wrap><p>*E value is considered as worst (1 - 5), poor (5 - 10), moderate (10 - 20), good (20 - 100) and excellent (&gt;100) [<xref ref-type="bibr" rid="scirp.73013-ref31">31</xref>] .</p><p>free enzyme was found to be moderate and was resulted in good enantiomeric excess of the Felodipine. However the enantiomeric purity of drug was not so excellent and hence it can be improved by enhancing the enantioselectivity of the enzyme. Immobilization will improve the enantioselectivity of the biocatalyst [<xref ref-type="bibr" rid="scirp.73013-ref36">36</xref>] . E value (enantioselectivity) of the reaction catalysed by the enzyme was improved from moderate to excellent after immobilization and hence the enantiomeric excess was found to be excellent (99.21%). The conversion yield of the drug was also enhanced by reaction catalysed by enzyme after immobilization.</p><p>These results were in agreement with the results obtained by Alnoch et al. (2015) and Lee et al. (2011). They conclude that enzyme immobilization improved enantioselectivity and further leads to increased enantiomeric purity. According to the Alnoch et al. (2015) immobilized Lip G9 enzyme showed excellent enantiomeic ratio (E &gt; 200) with high enantiomeric excess (ee% &gt; 95) and conversion rate (49%) than the free enzyme [<xref ref-type="bibr" rid="scirp.73013-ref37">37</xref>] . Similarly Lee et al. (2011) reported the enantioselectivity enhancement by the use of immobilized Burkhoderia cepacia lipase is about 2 - 11 fold compared to that by the free enzyme [<xref ref-type="bibr" rid="scirp.73013-ref36">36</xref>]. On the whole, immobilization of the biocatalyst has improved their enantioselectivity and hence resulted in good to excellent enantiomeric purity of the drug. Chromatograms of Felodipine after incubation with free and immobilized enzyme for 24 h were depicted in <xref ref-type="fig" rid="fig4">Figure 4</xref>(a) and <xref ref-type="fig" rid="fig4">Figure 4</xref>(b), respectively.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, immobilized lipase AP6 enzyme was found to be suitable biocatalyst for</p><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Chromatogram of Felodipine after incubation with (a) Free-enzyme; (b) Immobilized- enzyme</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/8-2270870x7.png"/></fig><p>the enantioselective conversion of racemic Felodipine with excellent enantiomeric excess, followed by immobilized A. niger and S. paucimobilis cultures.</p></sec><sec id="s6"><title>Acknowledgements</title><p>Authors are thankful for the financial assistance given by Science and Engineering Research Board (SR/SO/HS/0087/2010 dated 27/02/2012), Department of Science and Technology, New Delhi, India. Authors are also thankful to Aurobindo Pharmaceuticals Pvt Ltd, Hyderabad (India) for the kind gift of racemic Felodipine.</p></sec><sec id="s7"><title>Cite this paper</title><p>Vijitha, C., Swetha, E. and Veeresham, C. (2016) Enantioselective Conversion of Racemic Felodipine to S(−)-Felodipine by Aspergillus niger and Lipase AP6 Enzyme. Advances in Microbiology, 6, 1062-1074. http://dx.doi.org/10.4236/aim.2016.614099</p></sec></body><back><ref-list><title>References</title><ref id="scirp.73013-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leffingwell</surname><given-names> J.C. </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>Chirality and Bioactivity I. Pharmacology</article-title><source> Leffingwell Reports</source><volume> 3</volume>,<fpage> 1</fpage>-<lpage>27</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.73013-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Huisman, G.W. and Collier, S.J. (2013) On the Development of New Biocatalytic Processes for Practical Pharmaceutical Synthesis. Current Opinion in Chemical Biology, 17, 284-292.  
https://doi.org/10.1016/j.cbpa.2013.01.017</mixed-citation></ref><ref id="scirp.73013-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Nguyen, L.A., He, H. and Huy, C.P. (2006) Chiral Drugs: An Overview. International Journal of Biomedical Science, 2, 85-100.</mixed-citation></ref><ref id="scirp.73013-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Tishkov, V.I. and Zaitseva, E.A. (2008) Modern Trends in Biocatalytic Synthesis of Chiral Compounds. Moscow University Chemistry Bulletin, 63, 111-113.  
https://doi.org/10.3103/S0027131408020144</mixed-citation></ref><ref id="scirp.73013-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Santhosh Kumar, K.P. and Anju, C. (2005) Deracemization of Aromatic β-Hydroxy Esters Using Immobilized Whole Cells of Candida parapsilosis ATCC 7330 and Determination of Absolute Configuration by 1H NMR. Tetrahedron: Asymmetry, 16, 2790-2798.  
https://doi.org/10.1016/j.tetasy.2005.07.017</mixed-citation></ref><ref id="scirp.73013-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Thomson, M.J., Rhys-Williams, W., Hutt, A.J., Lioyd, A.W. and Hanlon, D.W. (1996) Demonstration of the Chiral Inversion of Ibuprofen by Verticillium lecanii in Non-Growing Cultures. Letters in Applied Microbiology, 23, 417-420.  
https://doi.org/10.1111/j.1472-765X.1996.tb01349.x</mixed-citation></ref><ref id="scirp.73013-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Lindmark, B., Ahnoff, M. and Persson, B.A. (2002) Enantioselective Determination of Felodipine in Human Plasma by Chiral Normal-Phase Liquid Chromatography and Electrospray Ionisation Mass Spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 27, 489-495. https://doi.org/10.1016/S0731-7085(01)00582-9</mixed-citation></ref><ref id="scirp.73013-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Eltze, M., Boer, R., Sanders, K.H., Boss, H., Ulrich, W.R. and Flocke1rzi, D. (1990) Stereoselective Inhibition of Thromboxane-Induced Coronary Vasoconstriction by 1,4-Dihydropyridine Calcium Channel Antagonists. Chirality, 2, 233-240.  
https://doi.org/10.1002/chir.530020408</mixed-citation></ref><ref id="scirp.73013-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Jin, J.Z., Li, H. and Zhang, J. (2010) Improved Synthesis of (S)-1-Phenyl-2-Propanol in High Concentration with Coupled Whole Cells of Rhodococcus erythropolis and Bacillus subtilis on Preparative Scale. Applied Biochemistry and Biotechnology, 162, 2075-2086.  
https://doi.org/10.1007/s12010-010-8983-3</mixed-citation></ref><ref id="scirp.73013-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kato, D.I., Miyamoto, K. and Ohta, H. (2005) Preparation of Optically Active 4-Chlorophenylalanine from Its Racemate by Deracemization Technique Using Transformant Escherichia coli Cells. Biocatalysis and Biotransformation, 23, 375-379.  
https://doi.org/10.1080/10242420500296295</mixed-citation></ref><ref id="scirp.73013-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Huang, H.R. and Xu, J.H. (2006) Preparation of (S)-Mandelic Acid from Racemate Using Growing Cells of Pseudomonas putida ECU1009 with R-Mandelate Degradation Activity. Biochemical Engineering Journal, 30, 11-15. https://doi.org/10.1016/j.bej.2006.01.010</mixed-citation></ref><ref id="scirp.73013-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Venisetty, R.K., Keshetty, S. and Veeresham, C. (2014) Biotransformation of Vincamine Using Microbial Cultures. IOSR Journal of Pharmacy and Biological Sciences, 9, 71-78.  
https://doi.org/10.9790/3008-09317178</mixed-citation></ref><ref id="scirp.73013-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Siódmiak, T., Rumiski, J.K. and Marszall, M.P. (2012) Application of Lipases from Candida rugosa in the Enantioselective Esterification of (R, S)-Ibuprofen. Current Organic Chemistry, 16, 1-6. https://doi.org/10.2174/138527212800194728</mixed-citation></ref><ref id="scirp.73013-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Xu, L.F., Lu, Y., Li, Y., and Xu, X. (2010) Comparision of Chiral Separations of Felodipine by High Performance Liquid Chromatography Using Two Celluose tris(4-methybenzoate) Stationary Phases. Chinese Journal of Chromatography, 28, 426-429.  
https://doi.org/10.3724/SP.J.1123.2012.00426</mixed-citation></ref><ref id="scirp.73013-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Faber, K. (2011) Biotransformations in Organic Chemistry. 6th Edition, Springer, Berlin.  
https://doi.org/10.1007/978-3-642-17393-6</mixed-citation></ref><ref id="scirp.73013-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Bhandarkar, S. and Neau, S. (2000) Lipase-Catalyzed Enantioselective Esterification of Flurbiprofen with N-Butanol. Electronic Journal of Biotechnology, 3, 195-201.</mixed-citation></ref><ref id="scirp.73013-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Gottemukkala, V.V., Saripella, K.K., Kadari, A.K. and Neau, S.H. (2008) Effect of Methyl branching of C8H18 Alkanes and Water Activity on Lipase Catalyzed Enantioselective Esterification of Ibuprofen. Electronic Journal of Biotechnology, 11, 1-12.  
https://doi.org/10.2225/vol11-issue1-fulltext-8</mixed-citation></ref><ref id="scirp.73013-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Liu, R. (2005) Enzymes as Catalysts in Synthesis of Enantiomerically Pure Building Blocks-Secondary Alcohols Bearing Two Vicinal Stereocentres. PhD Thesis, Kungliga Tekniska Hogskolan (KTH), Stockholm, Sweden.</mixed-citation></ref><ref id="scirp.73013-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Pena-Montes, C., Mondragon-Tintor, M.E., Castro-Rodriguez, J.A., Bustos-Jaimes, I., Navarro-Ocaria, A. and Farres, A. (2013) Immobilization and Biochemical Properties of the Enantioselective Recombinant NStcI Esterase of Aspergillus nidulans. Enzyme Research, 2013, Article ID: 928913. https://doi.org/10.1155/2013/928913</mixed-citation></ref><ref id="scirp.73013-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Ribeiro J.B., Ramos, A.S., Lopes, R.O., Silva, G.V.V. and Alves de Souza, R. (2014) Whole Cells in Enantioselective Reduction of Benzylacetoacetate. Brazilian Journal of Microbiology, 45, 929-932. https://doi.org/10.1590/S1517-83822014000300023</mixed-citation></ref><ref id="scirp.73013-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Tamalampudi, S., Hama, S., Tanino, T., Talukder, M.R., Kondo, A. and Fukuda, H. (2007) Immobilized Recombinant Aspergillus oryzae Expressing Heterologous Lipase: An Efficient Whole-Cell Biocatalyst for Enantioselective Transesterification in Non-Aqueous Medium. Journal of Molecular Catalysis B: Enzymatic, 48, 33-37.  
https://doi.org/10.1016/j.molcatb.2007.05.007</mixed-citation></ref><ref id="scirp.73013-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Hosseinpour, M.N., Najafpour, G.D., Yownsi, H. and Korrami, M. (2011) Submerged Culture Studies for Lipase Production by Aspergillus niger NCIM 584 on Soya Flour. Middle East Journal of Scientific Research, 7, 362-366.</mixed-citation></ref><ref id="scirp.73013-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Lee, J.K. and Kim, M.J. (2011) Room Temperature Solid-Phase Ionic Liquid-Immobilized Enzyme for Biocatalysis in Organic Solvent: Markedly Enhanced Enantioselectivity. Bulletin of the Korean Chemical Society, 32, 3149-3151.  
https://doi.org/10.5012/bkcs.2011.32.8.3149</mixed-citation></ref><ref id="scirp.73013-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Alnoch, R.C., Martini, V.P., Glogauer, A., Costa, A.C., Piovan, L., Muller-Santos, M., et al. (2015) Immobilization and Characterization of a New Regioselective and Enantioselective Lipase Obtained from a Metagenomic Library. PLoS ONE, 10, e0114945.  
https://doi.org/10.1371/journal.pone.0114945</mixed-citation></ref><ref id="scirp.73013-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Pawar, S.V., Meena, V.S., Kaushik, S., Kamble, A., Kumar, S., Chisti, Y. and Banerjee, U.S. (2012) Stereo-Selective Conversion of Mandelonitrile to (R)-(2)-Mandelic Acid Using Immobilized Cells of Recombinant Escherichia coli. Biotech, 2, 319-326.</mixed-citation></ref><ref id="scirp.73013-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Srisailam, K. and Veeresham, C. (2010) Biotransformation of Celecoxib Using Microbial Cultures. Applied Biochemistry and Biotechnology, 160, 2075-2089.  
https://doi.org/10.1007/s12010-009-8789-3</mixed-citation></ref><ref id="scirp.73013-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Venisetty, R.K., Keshetty, S. and Ciddi, V. (2011) Biotransformation of Silibinin (Silybin) Using Fungal Organisms. Indian Journal of Pharmaceutical Education and Research, 45, 384-391.</mixed-citation></ref><ref id="scirp.73013-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Carvalho, P. O., Contesini, F. J. and Ikegaki, M. (2006) Enzymatic Resolution of (R, S)-Ibuprofen and (R, S)-Ketoprofen by Microbial Lipases from Native and Commercial Sources. Brazilian Journal of Microbiology, 37, 329-337.  
https://doi.org/10.1590/S1517-83822006000300024</mixed-citation></ref><ref id="scirp.73013-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Hu, S.H., Tian, X.F. and Han, G.D. (1998) Novel Microbial Hydroxylation of 13-Ethyl-17β-Hydroxy-18, 19-Dinor-17α-Pregn-4-en-20-yn-3-One. Steroids, 63, 88-92.  
https://doi.org/10.1016/S0039-128X(97)00139-6</mixed-citation></ref><ref id="scirp.73013-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Barth, T., Conti, R., Pupo, M.T., Okano, L.T. and Bonato, P.S. (2012) Chiral HPLC Analysis of Donepezil, 5-O-Desmethyl Donepezil and 6-O-Desmethyl Donepezil in Culture Medium: Application to Fungal Biotransformation Studies. Analytical and Bioanalytical Chemistry, 404, 257-266. https://doi.org/10.1007/s00216-012-6107-3</mixed-citation></ref><ref id="scirp.73013-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Nie, Y., Xu, Y., Lv, T. F. and Xiao, R. (2009) Enhancement of Candida parapsilosis Catalyzing Deracemization of (R, S)-1-Phenyl-1,2-Ethanediol: Agitation Speed Control during Cell Cultivation. Journal of Chemical Technology and Biotechnology, 84, 468-472.  
https://doi.org/10.1002/jctb.2070</mixed-citation></ref><ref id="scirp.73013-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Comasseto, J.V., Andrade, L.H., Omori, A.T., Assis, L.F. and Meleiro Porto, A.L. (2004) Deracemization of Aryl Ethanols and Reduction of Acetophenones by Whole Fungal Cells of Aspergillus terreus CCT 4083, A. terreus CCT 3320 and Rhizopus oryzae CCT 4964. Journal of Molecular Catalysis B: Enzymatic, 29, 55-61.  
https://doi.org/10.1016/j.molcatb.2004.01.015</mixed-citation></ref><ref id="scirp.73013-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Damle, S.V., Patil, P.N. and Salunkhe, M. M. (2000) Biotransformations with Rhizopus arrhizus and Geotrichum candidum for the Preparation of (S)-Atenolol and (S)-Propranolol. Bioorganic &amp; Medicinal Chemistry, 8, 2067-2070.  
https://doi.org/10.1016/S0968-0896(00)00131-0</mixed-citation></ref><ref id="scirp.73013-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Da Silva, V.C.F., Contesini, F.J. and Carvalho P.D.O. (2009) Enantioselective Behaviour of Lipases from Aspergillus niger Immobilized in Different Supports. Journal of Industrial Microbiology &amp; Biotechnology, 36, 949-954. https://doi.org/10.1007/s10295-009-0573-4</mixed-citation></ref><ref id="scirp.73013-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Levadoux, W., Trani, M., Lortie, R., Kerr, D. and Groeau, A. (2002) Microbial Resolution of Baclofen by a New Isolate of Streptomyces halstedii. Journal of Bioscience and Bioengineerining, 93, 557-562. https://doi.org/10.1016/S1389-1723(02)80237-7</mixed-citation></ref><ref id="scirp.73013-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Hirrlinger, B., Stolz, A. and Knackmuss, H.J. (1996) Purification and Properties of an Amidase from Rhodococcus erythropolis MP50 which Enantioselectively Hydrolyzes 2-Arylpropionamides. Journal of Bacteriology, 178, 3501-3507.  
https://doi.org/10.1128/jb.178.12.3501-3507.1996</mixed-citation></ref><ref id="scirp.73013-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Mrutyunjay, S., Andrea, H., Thomas, P., Buser, H.R., Muller, M.D., Charu, D., et al. (2005) Enantioselective Transformation of α-Hexachlorocyclohexane by the Dehydrochlorinases LinA1 and LinA2 from the Soil Bacterium Spingomonas paucimobilis B90A. Applied and Environmental Microbiology, 71, 8514-8518.  
https://doi.org/10.1128/AEM.71.12.8514-8518.2005</mixed-citation></ref></ref-list></back></article>